Exact Sciences to Present Late-Breaking Data from ASCEND-2 S

First analysis from ASCEND-2 confirms high detection rates and specificity achieved with multi-biomarker approach in most aggressive cancers and those with no standard-of-care screening test1

...

Related Keywords

United States , San Diego , California , American , Tom Beer , Exchange Commission , Sciences Corp , Drug Administration , Sciences On Linkedin , American Cancer Society , Genomic Health Inc , Nasdaq , Sciences Corporation , Facebook , American Association For Cancer Research , Exact Sciences , American Association , Cancer Research , Annual Meeting , Chief Medical Officer , Multi Cancer Early Detection , Ascertaining Serial Cancer , Enable New Diagnostic , Exact Science , Early Through Elective , Genomic Health , Risk Factors , Annual Report , Quarterly Reports , Markets ,